Ibex Technologies (TSXV:IBT) Additional Paid-In Capital : C$1.38 Mil(As of Jan. 2024)

View and export this data going back to 1986. Start your Free Trial

What is Ibex Technologies Additional Paid-In Capital?

Ibex Technologies's quarterly additional paid-in capital increased from Jul. 2023 (C$1.08 Mil) to Oct. 2023 (C$1.21 Mil) and increased from Oct. 2023 (C$1.21 Mil) to Jan. 2024 (C$1.38 Mil).

Ibex Technologies's annual additional paid-in capital increased from Jul. 2021 (C$0.81 Mil) to Jul. 2022 (C$0.98 Mil) and increased from Jul. 2022 (C$0.98 Mil) to Jul. 2023 (C$1.08 Mil).

Ibex Technologies Additional Paid-In Capital Historical Data

The historical data trend for Ibex Technologies's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibex Technologies Additional Paid-In Capital Chart

Ibex Technologies Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Additional Paid-In Capital

Get a 7-Day Free Trial

0.71

0.79

0.81

0.98

1.08

Ibex Technologies Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Additional Paid-In Capital	Get a 7-Day Free Trial															1.05	1.05	1.08	1.21	1.38

Ibex Technologies Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Ibex Technologies Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Ibex Technologies's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Ibex Technologies (TSXV:IBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (TSXV:IBT) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

IBXNF:USA IBT:Germany

Address

5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7

Website

https://www.ibex.ca

Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (TSXV:IBT) Headlines

No Headlines